Evolve Biosystems snags $20 mln Series B
Davis, California-based Evolve Biosystems, a microbiome company, has raised $20 million in Series B financing. Spruce Capital Partners/MLS led the round with participation from other investors that include Horizons Ventures, Tate & Lyle Ventures, Bow Capital and Acre Venture Partners.
30 May 2017•1 min read
